Date | Shareholder name | Reason of Disclosure | Buy/Sell and Involved Shares |
Average Price per share | Current Holdings | % of Issued Shares |
04/08/2024 | China Resources Pharmaceutical Group Limited | 1711(L) | +165,595,721(L) | 217,054,121(L) | 42.18 | |
04/08/2024 | 1711(L) | +165,595,721(L) | 165,595,721(L) | 32.18 | ||
04/08/2024 | China Resources Company Limited | 1711(L) | +165,595,721(L) | 217,054,121(L) | 42.18 | |
11/04/2023 | Evodevo LTD | 1304(S) | -90,128,571(S) | 44,820,000(L) | 8.71 | |
11/04/2023 | Jung Hyun Chul | 1304(S) | -90,128,571(S) | 44,820,000(L) | 8.71 | |
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | Yan Kaijing | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | Tasly (Hong Kong) Pharmaceutical Investment Limited | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | Yan Xijun | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | Li Yunhui | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
31/03/2023 | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | ||
31/03/2023 | Wu Naifeng | 1303(L) | 90,128,571(L) | 191,595,721(L) | 37.23 | |
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | Tan Zheng | 1316(L) | 19,285,714(L) | 185,480,000(L) | 36.04 | |
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | 191,595,721(L) | 37.23 | |||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | Tasly (Hong Kong) Pharmaceutical Investment Limited | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | |
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
20/02/2023 | 1205(L) | 191,595,721(L) | 37.23 | |||
20/02/2023 | Tan Yueyue | 1316(L) | 6,714,286(L) | 59,794,286(L) | 11.62 | |
20/02/2023 | 1205(L) | -51,480,000(L) | 191,595,721(L) | 37.23 | ||
1 2 |
Remark: | (L) - Long Position, (S) - Short Position, (P) Lending; |
Real time quote last updated: 12/09/2024 09:22 | |
Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |